Recruitment

Recruitment Status
Completed

Inclusion Criteria

Patients over 18 years
Patient who have received in a lower range than 2 months of cervico-thoraco-abdominal-pelvic CT and scintigraphy in OctréoScan®
Patient who is suspected of endocrine tumors according to symptomatology, biology or imaging or pathological context (multiple endocrine neoplasia type 1)
...
Patients over 18 years
Patient who have received in a lower range than 2 months of cervico-thoraco-abdominal-pelvic CT and scintigraphy in OctréoScan®
Patient who is suspected of endocrine tumors according to symptomatology, biology or imaging or pathological context (multiple endocrine neoplasia type 1)
Search occult recurrence or suspicion of recurrence (clinical, laboratory, imaging doubtful)
staging of a known recurrence
Search of the primary tumor, especially in the case of the inaugural discovery of metastases
initial staging: this includes research multifocal disease or locoregional or metastatic extension if well-differentiated neuroendocrine tumor (grade 1 et/ou 2)
Patient who have signed an informed consent
Patient affiliated or beneficiary of regime of social security of a Member State of the European community

Exclusion Criteria

Patient with another evolutive cancer disease and/or treated for less than 5 years
Premenopausal woman without effective contraception (estrogen-progestin or intrauterine contraceptive device)
Persons placed under judicial protection
...
Patient with another evolutive cancer disease and/or treated for less than 5 years
Premenopausal woman without effective contraception (estrogen-progestin or intrauterine contraceptive device)
Persons placed under judicial protection
Patient unable to give their free and informed consent
Pregnant or lactating woman

Summary

Conditions
Neuroendocrine Tumors
Type
Observational
Design
  • Observational Model: Case-Only
  • Time Perspective: Prospective

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Inclusion Criteria

Patients over 18 years
Patient who have received in a lower range than 2 months of cervico-thoraco-abdominal-pelvic CT and scintigraphy in OctréoScan®
Patient who is suspected of endocrine tumors according to symptomatology, biology or imaging or pathological context (multiple endocrine neoplasia type 1)
...
Patients over 18 years
Patient who have received in a lower range than 2 months of cervico-thoraco-abdominal-pelvic CT and scintigraphy in OctréoScan®
Patient who is suspected of endocrine tumors according to symptomatology, biology or imaging or pathological context (multiple endocrine neoplasia type 1)
Search occult recurrence or suspicion of recurrence (clinical, laboratory, imaging doubtful)
staging of a known recurrence
Search of the primary tumor, especially in the case of the inaugural discovery of metastases
initial staging: this includes research multifocal disease or locoregional or metastatic extension if well-differentiated neuroendocrine tumor (grade 1 et/ou 2)
Patient who have signed an informed consent
Patient affiliated or beneficiary of regime of social security of a Member State of the European community

Exclusion Criteria

Patient with another evolutive cancer disease and/or treated for less than 5 years
Premenopausal woman without effective contraception (estrogen-progestin or intrauterine contraceptive device)
Persons placed under judicial protection
...
Patient with another evolutive cancer disease and/or treated for less than 5 years
Premenopausal woman without effective contraception (estrogen-progestin or intrauterine contraceptive device)
Persons placed under judicial protection
Patient unable to give their free and informed consent
Pregnant or lactating woman

Tracking Information

NCT #
NCT02134639
Collaborators
Not Provided
Investigators
  • Principal Investigator: Philippe FERNANDEZ, Professor University Hospital, Bordeaux
  • Philippe FERNANDEZ, Professor University Hospital, Bordeaux